Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry

Álvaro Urbano-Ispizua, MD PhD, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Marije Bartels, MD PhD, Christopher J. Patriquin, MD MSc, FRCPC, Britta Hoechsmann, MD, Alexey A. Maschan, MD, Amanda Wilson, PhD, Philippe Gustovic, MD, Hubert Schrezenmeier, MD

Blood (2018) 132 (Supplement 1): 3614.

https://doi.org/10.1182/blood-2018-99-111306

Published: 2018

Journal Articles

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Patricia Ferraz, MD, Arturo Pereira, MD PhD, María Suárez-Lledó, MD, Gonzalo Gutiérrez-García, MD, Francesc Fernández-Avilés, MD, Laura Rosinol, MD PhD, Teresa Solano, Noemí Llobet, Carla Ramos, Pedro Marín, MD, Alvaro Urbano-Ispizua, MD, Montserrat Rovira, MD, Carmen Martinez, MD PhD

Blood (2018) 132 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2018-99-112985

Published: 2018

Journal Articles

New Antibcma-CAR for Multiple Myeloma

Lorena Perez Amill, PhD, Guillermo Suñe Rodriguez, PhD, Amer Najjar, PhD, Maria Castella Castella, PhD, Alvaro Urbano-Ispizua, MD, Beatriz Martin-Antonio, PhD

Blood (2017) 130 (Supplement 1): 2062.

https://doi.org/10.1182/blood.V130.Suppl_1.2062.2062

Published: 2017

Journal Articles

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Alexander Roeth, MD, Scott T. Rottinghaus, MD, Anita Hill, MBChB (Hons), PhD, Jin Seok Kim, MD PhD, Hubert Schrezenmeier, MD, Louis Terriou, MD, Alvaro Urbano-Ispizua, MD, Richard A. Wells, MD DPhil, Jun Ho Jang, MD PhD, Jeff Szer, MB, BS, FRACP, Rasha Aguzzi, MS, Eric Scott Bachman, MD PhD, Andrew I. Damokosh, PhD, Lori Shafner, PhD, Jong-Wook Lee, MD

Blood (2017) 130 (Supplement 1): 3482.

https://doi.org/10.1182/blood.V130.Suppl_1.3482.3482

Published: 2017

Journal Articles

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Beatriz Martin-Antonio, PhD, Guillermo Suñe, PhD, Amer Najjar, PhD, Lorena Perez-Amill, Maria Velasco-de Andres, Francisco Lozano, Ester Lozano, Cristina Muñoz-Punedo, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, MD PhD

Blood (2016) 128 (22): 2115.

https://doi.org/10.1182/blood.V128.22.2115.2115

Published: 2016

Journal Articles

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

Beatriz Martin-Antonio, PhD, Erica Serrano, Guillermo Suñe, PhD, Lorena Perez, Marcos Calderón, Jose María Estanyol, PhD, Amer Najjar, PhD, Clara Bueno, PhD, Carlos Fernandez de Larrea, Alvaro Urbano-Ispizua, MD PhD

Blood (2015) 126 (23): 1787.

https://doi.org/10.1182/blood.V126.23.1787.1787

Published: 2015

Journal Articles

Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Antonio Medina Almeida, MD PhD, Camille L. Bedrosian, MD, Alexander Cole, DSc, MPH, Petra Muus, MD PhD, Hubert Schrezenmeier, MD, Jeff Szer, MB, BS, FRACP, Alvaro Urbano-Ispizua, MD PhD, Wendell F. Rosse, MD

Blood (2015) 126 (23): 3340.

https://doi.org/10.1182/blood.V126.23.3340.3340

Published: 2015

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Alvaro Urbano-Ispizua, MD, Steven Z. Pavletic, MD, Mary E. D. Flowers, MD, Mei-Jie Zhang, PhD, Jeanette Carreras, MPH, Sonali M. Smith, MD, David G. Maloney, MD, PhD, Silvia Montoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Stephen R Spellman, MBS, Mukta Arora, MD, MS, Wael Saber, MD, MS

Blood (2013) 122 (21): 2093.

https://doi.org/10.1182/blood.V122.21.2093.2093

Published: 2013

Journal Articles

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

Sally Arai, MD, Mukta Arora, MD, MS, Tao Wang, PhD, Wensheng He, PhD, MS, Daniel R. Couriel, MD, Alvaro Urbano-Ispizua, MD, Corey S. Cutler, MD, Stephen Spellman, MBS, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 3309.

https://doi.org/10.1182/blood.V122.21.3309.3309

Published: 2013

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

Gérard Socié, MD PhD, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Jeffrey Szer, MBBS, Alvaro Urbano-Ispizua, MD, Jaroslaw P. Maciejewski, MD, PhD, Robert A. Brodsky, MD, Monica Bessler, MD, PhD, Yuzuru Kanakura, MD, PhD, Wendell F. Rosse, MD, Gus Khursigara, PhD, Camille L. Bedrosian, MD, Peter Hillmen, MBChB, PhD

Blood (2012) 120 (21): 3480.

https://doi.org/10.1182/blood.V120.21.3480.3480

Published: 2012

Journal Articles

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Beatriz Martin-Antonio, Ph.D., Maria Suarez-LLedo, Montserrat Arroyes, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B. Nieto, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 468.

https://doi.org/10.1182/blood.V120.21.468.468

Published: 2012

Journal Articles

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

Alicia Báez, Beatriz Martin-Antonio, Ph.D., Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, María Victoria Barbado, Ph.D, Teresa Caballero-Velázquez, Jose Ignacio Piruat, Ph.D, Magdalena Carmona, MD, Jose Antonio Pérez-Simón, Sr., MD, PhD, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 3020.

https://doi.org/10.1182/blood.V120.21.3020.3020

Published: 2012

Journal Articles

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

Alicia Báez, Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, Estefania Garcia, Luis Ignacio Sanchez-Abarca, Ph.D., Beatriz Martin-Antonio, Ph.D., Alvaro Urbano-Ispizua, MD, Jose Antonio Pérez Simón, MD, PhD

Blood (2012) 120 (21): 588.

https://doi.org/10.1182/blood.V120.21.588.588

Published: 2012

Journal Articles

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Jeffrey Szer, MBBS, Petra Muus, MD, PhD, Alexander Roeth, MD, M.O Elebute, MD, FRCP, FRCPath, Antonio M. Risitano, MD, PhD, Hubert Schrezenmeier, MD, Jaroslaw P. Maciejewski, MD, PhD, Alvaro Urbano-Ispizua, MD, Carlos Manuel de Castro, III, MD, Gérard Socié, MD PhD, Robert A. Brodsky, MD

Blood (2012) 120 (21): 1260.

https://doi.org/10.1182/blood.V120.21.1260.1260

Published: 2012

Journal Articles

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

Alfons Navarro, PhD, Carmen Muñoz, PhD, Anna Gaya, MD, Antonio Martinez, MD, Marina Díaz Beyá, MD, Rut Tejero, Tania Díaz, PhD, Gerardo Ferrer, Msc, Alvaro Urbano-Ispizua, MD, Mariano Monzó, MD, PhD

Blood (2011) 118 (21): 1561.

https://doi.org/10.1182/blood.V118.21.1561.1561

Published: 2011

Journal Articles

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Blood (2011) 118 (21): 3094.

https://doi.org/10.1182/blood.V118.21.3094.3094

Published: 2011

Journal Articles

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

Beatriz Martin-Antonio, Damià Romero, David Gallardo, MD, PhD, Anna Bosch, Ildefonso Espigado, MD, PhD, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Nieto B Jose, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Alvaro Urbano-Ispizua, MD

Blood (2011) 118 (21): 3052.

https://doi.org/10.1182/blood.V118.21.3052.3052

Published: 2011

Journal Articles

G to C Transition At Position −173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)

Blood (2011) 118 (21): 2530.

https://doi.org/10.1182/blood.V118.21.2530.2530

Published: 2011

NARROW

Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

New Antibcma-CAR for Multiple Myeloma

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

G to C Transition At Position −173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only